Pathogenesis and Prevention of Hepatic Steatosis, Gastroenterol. Hepatol. (N Y), vol.11, pp.167-175, 2015. ,
Epidemiology of fatty liver: an update, World J. Gastroenterol, vol.20, pp.9050-9054, 2014. ,
Endocrine-disrupting chemicals and fatty liver disease, Nat. Rev. Endocrinol, vol.2017, pp.445-457 ,
The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease, Curr. Mol. Med, vol.12, pp.68-82, 2012. ,
Endocrine-disrupting Chemicals: Review of Toxicological Mechanisms Using Molecular Pathway Analysis, J. Cancer Prev, vol.20, pp.12-24, 2015. ,
Endocrine Disruptors: Data-based survey of in vivo tests, predictive models and the Adverse Outcome Pathway, Regul. Toxicol. Pharmacol, vol.86, pp.18-24, 2017. ,
, The History and Development of Quantitative Structure-Activity Relationships (QSARs). IJQSPR, vol.1, p.43, 2016.
Predicting druginduced hepatotoxicity using QSAR and toxicogenomics approaches, Chem. Res. Toxicol, vol.24, pp.1251-1262, 2011. ,
Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA), Regul. Toxicol. Pharmacol, vol.70, pp.629-640, 2014. ,
, Arch. Toxicol, vol.91, pp.3477-3505, 2017.
Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes, Regul. Toxicol. Pharmacol, vol.71, pp.463-477, 2015. ,
Adverse Outcome Pathways: a Conceptual Framework to Support Ecotoxicology Research and Risk Assessment, Environ. Toxicol. Chem, vol.29, pp.730-741, 2010. ,
Multivariate models for prediction of human skin sensitization hazard, J. Appl. Toxicol, vol.37, pp.347-360, 2017. ,
Highlight report: Launch of a large integrated European in vitro toxicology project: EU-ToxRisk, Arch. Toxicol, vol.90, pp.1021-1024, 2016. ,
How Adverse Outcome Pathways Can Aid the Development and Use of Computational Prediction Models for Regulatory Toxicology, Toxicol. Sci, vol.155, issue.17, pp.5-12, 2007. ,
, CERAPP: Collaborative Estrogen Receptor Activity Prediction Project. Environ. Health Perspect, vol.124, pp.1023-1033, 2016.
Optimal classifier for imbalanced data using Matthews Correlation Coefficient metric, PLoS One, vol.12, 2017. ,
Editorial: Tox21 Challenge to Build Predictive Models of Nuclear Receptor and Stress Response Pathways As Mediated by Exposure to Environmental Toxicants and Drugs. Front, Environ. Sci, issue.5, 2017. ,
Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in mice, EPA. Toxicity ForeCaster (ToxCast?) Data, vol.142, issue.23, pp.361-374, 2014. ,
Homogeneous reporter system enables quantitative functional assessment of multiple transcription factors, Nat. Methods, vol.5, pp.253-260, 2008. ,
Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA's ToxCast program, Chem. Res. Toxicol, vol.23, issue.27, pp.578-590, 2010. ,
A generalizable definition of chemical similarity for read-across, J. Cheminform, 2017. ,
Editor's Highlight: Analysis of the Effects of, Cell Stress and Cytotoxicity on In Vitro Assay Activity Across a Diverse Chemical and Assay Space. Toxicol. Sci, vol.152, pp.323-339, 2016. ,
Comparison of the predicted and observed secondary structure of T4 phage lysozyme, Biochim. Biophys. Acta, vol.405, pp.442-451, 1975. ,
Describing the validity of carcinogen screening tests, Br. J. Cancer, vol.39, pp.87-89, 1979. ,
A method of comparing the areas under receiver operating characteristic curves derived from the same cases, Radiology, vol.148, pp.839-882, 1983. ,
Principles of QSAR models validation: internal and external, QSAR Comb. Sci, vol.26, pp.694-701, 2007. ,
Methods for reliability and uncertainty assessment and for applicability evaluations of classification-and regression-based QSARs, Environ. Health Perspect, vol.111, issue.36, pp.5-32, 2001. ,
Attribute bagging: improving accuracy of classifier ensembles by using random feature subsets, Data Analysis, vol.36, pp.319-326, 2003. ,
Using Random Forest to Learn Imbalanced Data, 2004. ,
Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. The report and recommendations of ECVAM Workshop 52, ATLA, Altern. Lab. Anim, vol.2, issue.43, pp.155-173, 2002. ,
Three useful dimensions for domain applicability in QSAR models using random forest, J. Chem. Inf. Model, vol.52, pp.814-823, 2012. ,
Integrating computational methods to predict mutagenicity of aromatic azo compounds, J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev, vol.35, issue.46, pp.239-257, 2017. ,
The LysosomalMitochondrial Axis in Free Fatty Acid-Induced Hepatic Lipotoxicity, Hepatology, vol.47, pp.1495-1503, 2008. ,
Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4, J. Chem. Inf. Model, vol.47, issue.49, pp.2534-2547, 2005. ,
Application of random forest approach to QSAR prediction of aquatic toxicity, J. Chem. Inf. Model, vol.49, pp.2481-2488, 2009. ,
Random forest: a classification and regression tool for compound classification and QSAR modeling, J. Chem. Inf. Comput. Sci, vol.43, pp.1947-1958, 2003. ,
Chemical and in vitro biological information to predict mouse liver toxicity using recursive random forests, SAR QSAR Environ. Res, vol.27, pp.559-572, 2016. ,
Prediction of in vitro and in vivo oestrogen receptor activity using hierarchical clustering, SAR QSAR Environ. Res, vol.27, pp.17-30, 2016. ,
Mining Chemical Activity Status from High-Throughput Screening Assays, PLoS One, vol.10, p.144426, 2015. ,
Tox21Challenge to Build Predictive Models of Nuclear Receptor and Stress Response Pathways as Mediated by Exposure to Environmental Chemicals and Drugs, Front. Environ. Sci, p.3, 2016. ,
Developing and validating predictive decision tree models from mining chemical structural fingerprints and high-throughput screening data in PubChem, J. Chem. Inf. Model, vol.9, issue.57, pp.34-42, 2007. ,
Best Practices for QSAR Model Development, Validation, and Exploitation, Mol. Inf, vol.29, pp.476-488, 2010. ,
Virtual screening-an overview, Drug Discov. Today, vol.3, pp.160-178, 1998. ,
Principles for the Validation, for Regulatory Purposes, of (Quantitative) Structure-Activity Relationship Models, 2018. ,
Bayesian statistical inference for SBML-coded systems biology models, Bioinformatics, vol.25, pp.1453-1454, 2009. ,
URL : https://hal.archives-ouvertes.fr/ineris-00961935
Dempster-Shafer theory applied to regulatory decision process for selecting safer alternatives to toxic chemicals in consumer products, Integr. Environ. Assess. Manag, vol.10, pp.12-21, 2014. ,